Neuroprotective Therapy for Stroke and Ischemic Disease (häftad)
Häftad (Paperback / softback)
Antal sidor
Softcover reprint of the original 1st ed. 2017
Springer International Publishing AG
Zhang, John H.
86 Tables, color; 71 Illustrations, color; 34 Illustrations, black and white; XVII, 795 p. 105 illus
Antal komponenter
1 Paperback / softback
Neuroprotective Therapy for Stroke and Ischemic Disease (häftad)

Neuroprotective Therapy for Stroke and Ischemic Disease

Häftad Engelska, 2018-07-17
Skickas inom 10-15 vardagar.
Fri frakt inom Sverige för privatpersoner.
Finns även som
Visa alla 1 format & utgåvor
A critical and comprehensive look at current state-of-the-art scientific and translational research being conducted internationally, in academia and industry, to address new ways to provide effective treatment to victims of ischemic and hemorrhagic stroke and other ischemic diseases. Currently stroke can be successfully treated through the administration of a thrombolytic, but the therapeutic window is short and many patients are not able to receive treatment. Only about 30% of patients are "cured" by available treatments. In 5 sections, the proposed volume will explore historical and novel neuroprotection mechanisms and targets, new and combination therapies, as well as clinical trial design for some of the recent bench-side research.
Visa hela texten

Passar bra ihop

  1. Neuroprotective Therapy for Stroke and Ischemic Disease
  2. +
  3. Cellular and Molecular Approaches to Regeneration and Repair

De som köpt den här boken har ofta också köpt Cellular and Molecular Approaches to Regenerati... av Paul A Lapchak, John H Zhang (inbunden).

Köp båda 2 för 5258 kr


Har du läst boken? Sätt ditt betyg »

Bloggat om Neuroprotective Therapy for Stroke and Is...

Övrig information

Paul Lapchak is the director of translational neurodegenerative disease research at Cedars-Sinai Medical Center in California. Dr. Lapchak obtained his Ph.D. at McGill University and University of Southern California. His lab focuses on developing new therapeutic approaches to treat different types of stroke as well as experimenting with neuroprotective agents. In addition, his research extends to drug development using the rabbit embolic stroke model and multiple assay methods. Dr. Lapchak is editor-in-chief of the Journal of Neurology & Neurophysiology and associate editor of the journal Translational Stroke Research. With over twenty years of experience and numerous publications, Dr. Lapchak is a leading expert in his field of translational stroke research. John Zhang is doctor and professor in the departments of Anesthesiology, Neurosurgery, Neurology, and Physiology at the Loma Linda University School of Medicine in California. He obtained his Ph.D. at the University of Alberta, Canada and his MD at Chongqing University of Medical Sciences, China. His lab focuses on hemorrhagic and ischemic stroke, specifically on cerebral vascular biology, neuroprotection, gene therapy, signaling pathways, and apoptosis. Dr. Zhang is on the editorial boards of the journals Surgical Neurology and Neurological Research. Coauthor of countless publications, Dr. Zhang is also a member of several professional societies and participates in current discussions of stroke disease research and neuroprotection.